| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| Chain A, Methyltransferase Wbdd | 0 | 1 | 0 | 1 |
| thioredoxin reductase | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| TDP1 protein | 3 | 0 | 0 | 3 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| Parkin | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 1 | 0 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 0 | 1 | 0 | 2 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PLK4 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 1 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Bromodomain-containing protein 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Integrin beta-3 | 1 | 0 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase pim-1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 1 | 3 |
| Casein kinase II subunit alpha' | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 1 | 3 |
| Proteinase-activated receptor 1 | 0 | 0 | 0 | 1 |
| Bromodomain-containing protein 2 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 1 | 3 |
| Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 2 | 0 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0 | 1 | 0 | 3 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 1 | 0 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Serine/threonine-protein kinase PLK1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 1 | 3 |
| Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
| DNA-dependent protein kinase catalytic subunit | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 2 | 0 | 2 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 2 | 0 | 2 |
| Bromodomain-containing protein 3 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase pim-3 | 0 | 1 | 0 | 1 |
| Phosphoinositide 3-kinase regulatory subunit 5 | 0 | 1 | 0 | 1 |
| GABA theta subunit | 2 | 0 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 1 | 3 |
| Serine/threonine-protein kinase PLK3 | 0 | 2 | 0 | 2 |
| Serine/threonine-protein kinase PLK2 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
| GLI family zinc finger 3 | 4 | 0 | 0 | 4 |
| AR protein | 4 | 0 | 0 | 4 |
| retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
| retinoid X nuclear receptor alpha | 3 | 0 | 0 | 3 |
| estrogen nuclear receptor alpha | 4 | 0 | 0 | 4 |
| peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
| activating transcription factor 6 | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
| Histone H2A.x | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
| Glutamate receptor 2 | 2 | 0 | 0 | 2 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
| Type-1A angiotensin II receptor | 0 | 4 | 2 | 6 |
| Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
| Type-1B angiotensin II receptor | 0 | 4 | 0 | 4 |
| Type-1 angiotensin II receptor | 0 | 4 | 3 | 9 |
| Type-2 angiotensin II receptor | 0 | 4 | 0 | 4 |
| Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
| geminin | 2 | 0 | 0 | 2 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 3 | 2 | 5 |
| Beta-1 adrenergic receptor | 0 | 2 | 2 | 4 |
| Beta-3 adrenergic receptor | 0 | 0 | 2 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 1 | 3 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
| arylsulfatase A | 1 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
| glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
| G | 1 | 0 | 0 | 1 |
| peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
| Interferon beta | 2 | 0 | 0 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 2 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 2 | 0 | 0 | 2 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| SMAD family member 2 | 1 | 0 | 0 | 1 |
| SMAD family member 3 | 1 | 0 | 0 | 1 |
| Smad3 | 1 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
| progesterone receptor | 2 | 0 | 0 | 2 |
| estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
| farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
| pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
| IDH1 | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
| Vpr | 1 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 1 | 3 |
| Glucocorticoid receptor | 0 | 2 | 1 | 3 |
| Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
| Progesterone receptor | 0 | 2 | 1 | 3 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Mineralocorticoid receptor | 0 | 2 | 0 | 3 |
| Androgen receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 3 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 1 | 1 | 2 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Ataxin-2 | 1 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |